Search Results
Found 1 results
510(k) Data Aggregation
(29 days)
The AXS Infinity LS Plus Long Sheath is indicated for the introduction of interventional devices into the peripheral, coronary, and neuro vasculature.
The AXS Infinity LS Plus Long Sheath is a variable stiffness catheter that has a catheter shaft reinforced with a stainless-steel mixed coil design (single wind and cross coil wind). It has a radiopaque Platinum/Iridium marker band on the distal end. The distal 10 cm of the AXS Infinity LS Plus Long Sheath has a hydrophilic coating which reduces the insertion force and allows the catheter to traverse the vasculature more easily. The catheter has a maximum average outer diameter of 0.109", where no point is > 0.112" and a nominal inner diameter of 0.091". It is available in three working lengths: 70 cm, 80 cm, and 90 cm. The AXS Infinity LS Plus Long Sheath has a PTFElined lumen. The AXS Infinity LS Plus Long Sheath is inserted at a vascular access point to provide access to the target site and once in place, provides a reinforcing conduit for other intravascular devices. Accessories included with the device are a Tuohy-Borst Hemostasis Valve and a Vessel Dilator. The accessories are identical to those in the previous clearance (K172468). The AXS Infinity LS Plus Long Sheath is supplied sterile, non-pyrogenic, and intended for single use only.
This document is a 510(k) summary for the AXS Infinity LS Plus Long Sheath, a medical device. It describes the non-clinical testing performed to demonstrate its substantial equivalence to a predicate device.
Here's an analysis of the acceptance criteria and the studies performed, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria and reported device performance are presented across several tables in the document, categorized by the type of testing.
Biocompatibility Testing (Table 5-3, page 9):
| # | Tests | Acceptance Criteria | Results (Pass/Fail/Other) |
|---|---|---|---|
| 1 | MEM elution, 48 hr. inc., triplicate L929, 24 hr. ext. (non-implant) | Replicate results from negative and media controls must all receive a 0-1 reactive grade and replicate positive controls must all receive a 3-4 reactivity grade. | Pass. All test method acceptance criteria were met. No cytotoxicity or cell lysis. Score: 0 |
| 2 | Magnusson-Kligman Method, 2 extracts | Replicate results from negative and media controls must all receive a 0-1 reactive grade and replicate positive controls must all receive a 3-4 reactivity grade | Pass. The USP 0.9% Sodium Chloride for injection (NaCl) and Cottonseed Oil (CSO) extracts of the test article elicited no reaction at the challenge (0% sensitization), following an induction phase. The test article is classified as a non-sensitizer. |
| 3 | Intracutaneous Toxicity (ISO), 2 extracts | The test article extracts must not produce a significantly greater biological reaction than the control. | Pass. The test article (device) sites did not show a significantly greater biological reaction than the sites injected with the control article. |
| 4 | Material Mediated Pyrogen | The test article extract must not produce a pyrogenic response. | Pass. The test article (device) is considered non-pyrogenic. |
| 5 | Systemic Injection (ISO), 2 extracts | The test article extracts must not produce a significantly greater biological reaction than the control. | Pass. The test article (device) extracts did not cause acute adverse effects under the conditions of this assay. |
| 6 | Hemolysis, ASTM Method, indirect contact (human blood) | The negative control must produce a corrected hemolytic index of less than 2%. The positive control must produce a corrected hemolytic index of greater than 5% above the negative control. The hemolytic index of the test article must be rated 0-2 (Non-Hemolytic) when corrected with a negative control. | Pass. The difference between the hemolytic indexes of the test article and the negative control is 0.00 percent for direct contact, and 0.44 for extract; this places the test article in the non-hemolytic range. |
| 7 | Hemolysis, ASTM Method, direct contact (human blood) | The concentration of SC5b-9 in the test article should be comparable to the predicate and the negative control. | This entry appears to be misaligned, the result is missing but likely linked to item 8. |
| 8 | Complement Activation, SC5b-9 | Clotting times are evaluated using analysis of variance and compared to the clotting time of the negative control. When a predicate product is tested, the results of the test article are compared to predicate values. | Pass. The SCb5-9 results for the test article were statistically similar to the predicate device after 30 minutes exposure and only marginally higher than the predicate device for 60 and 90 minutes exposure. The SCb5-9 results for the test article were statistically similar to the negative control after 30- and 90-minutes exposure and only marginally higher than the negative control following 60 minutes exposure. |
| 9 | Partial Thromboplastin Time (PTT), Human Plasma | Clotting times are evaluated using analysis of variance and compared to the clotting time of the negative control. When a predicate product is tested, the results of the test article are compared to predicate values. The positive control should show a significantly shortened clotting time when compared to the negative control. A p value of less than 0.050 demonstrates a statistically significant difference. | Pass. The average clotting time for the test article was compared to the predicate and negative control and was deemed similar when p values of clotting times were compared. Hence, this result is considered acceptable. |
| 10 | Dog Thrombogenicity | The thrombogenic potential of test article will be comparable or less than the Predicate device. | Pass. The test article thrombogenic potential was less than and comparable to the Predicate device. |
Design Verification - Bench Testing (Table 5-4, page 11):
| Design Requirement/Test Name | Acceptance Criteria | Results |
|---|------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Tensile Strength | Peak tensile force shall be ≥ 15N at all joints | Pass. Two deviations were identified. The deviations did not impact the outcome of Tensile Strength testing. Refer to the summary of the deviations provided below. In all cases, the 90/95 confidence/reliability was higher than the specification of 15N. |
| PTFE Delamination | PTFE liner shall not delaminate. Any observed delamination within 1 mm of the cut is not considered a failure. | Pass. All samples did not exhibit any PTFE delamination. |
| Torque Strength | Catheter shall withstand at least one 360 degree turn of the hub | Pass. A reliability analysis was completed at 85% reliability and 95% confidence (8.50 turns minimum torque strength). |
| Catheter Burst | Product shall not burst below 44 psi | Pass. The minimum catheter burst pressure recorded was 119.7 psi. In addition, the 85%/95% lower bound value at 117.28 psi is greater than the lower specification limit of 44 psi. |
| Leak (Liquid) | No liquid leaking from hub and catheter shaft at 44 psi for 30 second duration | Pass. All units passed the liquid leak test. |
| Leak (Air) | No air shall leak into the catheter assembly during manual aspiration | Pass. All units passed air leakage testing. |
| Catheter Dimensional Testing (ID, OD, and Working Lengths) | The ID of the catheters shall be ≥ 0.090" | Pass. 95% confidence lower bound is 0.0914", which is greater than the lower specification limit of 0.090". |
| | The average OD of the catheter shall be ≤ 0.110" over the length of the catheter where no point measured shall be > 0.112" maximum | Pass. The average OD, the 95% confidence, 90% reliability upper bound is 0.109886" which is less than 0.110". For max OD, the 95% confidence, 90% reliability upper bound is 0.0110" which is less than 0.112", max OD. |
| | The catheter working length shall be within 2 cm of nominal | Pass. For catheter working length, the 95% confidence, 90% reliability lower bound is 89.72 cm and the upper bound is 90.23 cm, which is within 2 cm of nominal (90 cm). |
| Chemical Compatibility | Product shall withstand exposure to the following chemicals without degradation: Saline, Dextrose, Heparin, Contrast | Pass. All units passed chemical compatibility. |
| Kink Resistance | The kink resistance shall be: ≤ 0.215" at the distal most material ≤ 2" at the proximal most material | Pass. All units passed kink resistance. |
| Visual Inspection (Transitions and Tip) | The catheter shall have progressively lower durometer moving from proximal end to distal tip with smooth transition points to facilitate navigation through tortuous vascular anatomy. The catheter's distal tip shall be visibly tapered. | Pass. Units were inspected for smooth transitions and rounded tip. All units met the acceptance criteria and passed the transitions and tip visual inspection. |
Shelf Life (3-Year Accelerated Aging) (Table 5-5, page 14):
| Design Requirement/Test Name | Acceptance Criteria | Results |
|---|------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Tensile Strength | Peak tensile force shall be ≥ 15N at all joints | Pass. All samples had a peak tensile force of less than 15N. |
| PTFE Delamination | PTFE liner shall not delaminate. Any observed delamination within 1 mm of the cut is not considered a failure. | Pass. All samples did not exhibit any PTFE delamination. |
| Torque Strength | Catheter shall withstand at least one 360 degree turn of the hub | Pass. All samples withstood at least one 360 degree turn of the hub. |
| Catheter Burst | Product shall not burst below 44 psi | Pass. All samples had a burst rate greater than the lower specification limit of 44 psi. |
| Leak (Liquid) | No liquid leaking from hub and catheter shaft at 44 psi for 30 second duration | Pass. All units passed the liquid leak test. |
| Leak (Air) | No air shall leak into the catheter assembly during manual aspiration | Pass. All units passed air leakage testing. |
| Catheter Dimensional Testing (ID, OD, and Working Lengths) | The ID of the catheters shall be ≥ 0.090" | Pass. The ID of all catheters was greater than the lower specification limit of 0.090". |
| | The average OD of the catheter shall be ≤ 0.110" over the length of the catheter where no point measured shall be > 0.112" maximum | Pass. The average OD of all catheters was less than 0.110". The max OD of all catheters was less than 0.112". |
| | The catheter working length shall be within 2 cm of nominal | Pass. The working length of all catheters was within 2 cm of nominal. |
| Kink Resistance | The kink resistance shall be: ≤ 0.215" at the distal most material ≤ 2" at the proximal most material | Pass. All units passed kink resistance. |
| Visual Inspection (Transitions and Tip) | The catheter shall have progressively lower durometer moving from proximal end to distal tip with smooth transition points to facilitate navigation through tortuous vascular anatomy. The catheter's distal tip shall be visibly tapered. | Pass. Units were inspected for smooth transitions and rounded tip. All units met the acceptance criteria and passed the transitions and tip visual inspection. |
Sterilization Testing (Table 5-6, page 17):
| Test Name | Acceptance Criteria | Results |
|---|---|---|
| EO Residuals Testing | The total EO content of the AXS Infinity LS Plus was no more than 4 mg and the ECH level no more than 9 mg following 12 hours heated aeration for 1X product and 2X product. | Pass. |
| Bioburden Testing | The average corrected bioburden count should be less than 111 CFU/product unit. The types/groupings of microorganisms present in the bioburden should be similar to those observed with the exiting products. | Pass. |
| LAL Testing | LAL results were < 2.15 EU/device (0.06 EU/ml). | Pass. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document does not explicitly state a specific numerical sample size for each individual test. Instead, it generally refers to "all samples," "all units," or implies multiple replicates by stating "replicate results" or "triplicate." For Design Verification (Bench Testing) and Shelf Life (Accelerated Aging), a reliability analysis is mentioned for some tests (e.g., Tensile Strength, Torque Strength, Catheter Burst, Dimensional Testing), which typically involves a defined sample size to achieve the stated confidence and reliability levels (e.g., 90/95 confidence/reliability). However, the exact sample numbers are not provided in this summary.
- Data Provenance: The studies are described as "non-clinical data," "benchtop testing," "simulated-use testing," and "animal testing." No human clinical data was used for this submission. The testing was conducted by Stryker Neurovascular. The data is prospective in nature as it was generated specifically for this 510(k) submission to demonstrate equivalence. The provenance is internal to the manufacturer, Stryker Neurovascular, based in Fremont, CA, USA.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications
This submission pertains to a physical medical device (catheter) and relies on engineering and laboratory test results rather than expert interpretation of medical images or other diagnostic data. Therefore, the concept of "experts" establishing a "ground truth" in the clinical diagnostic sense is not directly applicable here. The "ground truth" for each non-clinical test is defined by the established and accepted engineering standards and validated test methodologies (e.g., ISO, ASTM standards, internal validated protocols). The "experts" would be the qualified engineers and technicians performing and verifying these tests. Their specific numbers and qualifications are not detailed in this summary.
4. Adjudication Method for the Test Set
Not applicable. This is not a study involving human interpretation of data requiring adjudication. The results are quantitative measurements against predefined acceptance criteria.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No. This document explicitly states, "No clinical study was conducted as bench testing and previously performed animal testing was determined to be sufficient for verification and validation purposes" (page 17). Therefore, no MRMC study or AI-related comparative effectiveness study was performed.
6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done
No. This device is a physical medical catheter, not an algorithm or AI product.
7. The Type of Ground Truth Used
The ground truth for the non-clinical tests is based on:
- Established Industry Standards and Regulations: Such as ISO 10993-1:2018 for Biocompatibility, EN ISO 14971:2012 for Risk Assessment, and ASTM methods for Hemolysis.
- Pre-determined Acceptance Criteria: Developed based on the device's intended use, safety, performance, and comparison to the predicate device.
- Physical Measurements and Chemical Analyses: Performed in a laboratory setting.
8. The Sample Size for the Training Set
Not applicable. This device is not an AI/ML algorithm that requires a training set. The tested devices are physical products.
9. How the Ground Truth for the Training Set Was Established
Not applicable. As noted above, there is no training set for this type of device.
Ask a specific question about this device
Page 1 of 1